Conservative Treatment and Secondary Prevention of PAD (Peripheral Artery Disease)

被引：0
|
作者：
Muehlberg, Katja S. [1 ,2 ]
机构：
[1] Univ Klinikum Leipzig, Med Klin & Poliklin Angiol, Leipzig, Germany
[2] Univ Klinikum Leipzig, Klin & Poliklin Angiol, Liebigstr 20, D-04103 Leipzig, Germany
来源：
ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE | 2024年 / 59卷 / 02期
关键词：
Gehtraining; Thrombozytenaggregationshemmer; Lipidsenker; Raucherentwohnung; walking training; platelet aggregation inhibitors; lipid-lowering drugs; smoking cessation; METAANALYSIS; CILOSTAZOL; EFFICACY; RISK;
D O I：
10.1055/a-2250-8816
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
The immediate and long-term success of endovascular and surgical revascularization crucially depends on the conservative treatment of the PAD. The ,,gentle, preserving" treatment should be understood as he absolutely basic therapy for every PAD patient, because conservative treatment adresses the ,,big five" of atherosclerotic risk factors. This article presents both the full spectrum of pharmacological and non-pharmacological strategies.
引用
收藏
页码：114 / 121
页数：8
相关论文
共 50 条
  • [1] Peripheral arterial disease (PAD):: secondary prevention
    Völler, H
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (37) : 1870 - 1872
  • [2] Conservative therapy and secondary prevention of PAD
    Muehlberg, Katja S.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (20) : 1293 - 1300
  • [3] SECONDARY PREVENTION IN PERIPHERAL ARTERY OCCLUSIVE DISEASE
    BOLLINGER, A
    [J]. THERAPEUTISCHE UMSCHAU, 1987, 44 (09) : 682 - 685
  • [4] Recovery of endothelial function in microvessels in patients with peripheral artery disease (PAD) after conservative and surgery treatment
    Zubareva, Nadezhda
    Parshakov, Aleksey
    Podtaev, Sergey
    Frick, Peter
    Mizeva, Irina
    [J]. SARATOV FALL MEETING 2018: COMPUTATIONS AND DATA ANALYSIS: FROM NANOSCALE TOOLS TO BRAIN FUNCTIONS, 2019, 11067
  • [5] Recommendations on conservative therapy and secondary prevention of peripheral arterial disease (PAD): an evidence-based information brochure for sufferers
    Rosenberg, Yvonne
    Goertz, Hartmut
    Rother, Ulrich
    Uhl, Christian
    Stavroulakis, Konstantinos
    Pfeiffer, Manfred
    Pfeiffer-Krahl, Mechtild
    Behrendt, Christian-Alexander
    [J]. GEFASSCHIRURGIE, 2022, 27 (01): : 39 - 45
  • [6] SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN PERIPHERAL ARTERY DISEASE PATIENTS
    Rashid, S. T.
    Bangee, S.
    [J]. BRITISH JOURNAL OF SURGERY, 2021, 108 : 31 - 31
  • [7] Fibrinogen apheresis (FA) in the treatment of peripheral artery disease (PAD)
    Ramunni, A.
    Brescia, P.
    Plantamura, M.
    Quaranta, D.
    Saliani, M. T.
    Coratelli, P.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 98 - 98
  • [8] Anti-Thrombotic Treatment of Patients with Peripheral Artery Disease (PAD)
    Espinola-Klein, Christine
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2018, 143 (15) : 1060 - 1064
  • [9] Medical Therapy for Secondary Prevention of Atherothrombotic Events in Peripheral Artery Disease
    Morrison, Justin T.
    Hsia, Judith
    Bonaca, Marc P.
    [J]. HEART INTERNATIONAL, 2021, 15 (01): : 14 - 19
  • [10] Indicators of outcome quality for multimodal invasive treatment of peripheral artery disease (PAD)
    Uhl, C.
    Ruemenapf, G.
    Goertz, H.
    Boeckler, D.
    Behrendt, C-A
    Pleye, J.
    Rother, U.
    [J]. GEFASSCHIRURGIE, 2020, 25 (07): : 560 - 567
12345